Additionally, loss of AR was independent of other hormone receptors, such as ER and PR, and was associated with an earlier time of breast cancer diagnosis (3 years earlier than AR-positive patients and 6 years earlier for AA patients). The gene discussed is AR; the disease is breast cancer.